pharma · Chronic obstructive pulmonary disease (COPD) · Partial Epilepsy in Children and Adolescents
Bial Portela &
Bial Portela & Companhia S.A.
Bial Portela & is a pharma organization headquartered in EU. Primary therapeutic focus areas include Chronic obstructive pulmonary disease (COPD), Partial Epilepsy in Children and Adolescents, Intermediate and high-risk
EU HQ
EMA registrant Type
Company details
- Status
- Public
- HQ
- EU
- Programs
- 7
- Drugs
- 7
- Patents
- 3
BIA-28-6156-111
Phase 1 · other · Parkinson's disease
BIA-28-6156-111 for Parkinson's disease is a Phase 1 program (other) at Bial Portela & Companhia S.A. with 1 ClinicalTrials.gov record(s).
Internal code BIA-28-6156-111
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Bial Portela & Companhia S.A.
- Phase
- Phase 1
- Modality
- other
- Indication
- Parkinson's disease
- Status
- active
- Trials
- 1